retatrutide nejm 2023 obesity trial ly3437943 First phase 3 data, a Triumph of Science! Retatrutide Weight Loss Results |

A.SmithW

GLP-1 medications like semaglutide and tirzepatide have produced clinical trial results previously only associated with bariatric surgery and access to these medications through medically supervised programs is now widely available

Formulated with high-quality glutathione, these table

5 Common Reasons Your Weight Loss Has Slowed 1

A 2021 study published in the New England Journal of Medicine (Wilding et al., NEJM, 2021) found that semaglutide 2.4 mg produced an average weight loss of approximately 14.9% of body weight over 68 weeks in adults with obesity, compared to 2.4% in the placebo group

10.1186/1742-2094-8-69 308 YangL.ZhaoW.GongX.YueD.LiuY.TianY.et al (2023)